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A report of the meeting ‘Translational Control’, Cold Spring
Harbor, USA, 3-7 September 2008.
More than 400 scientists contributed to this year’s highly
successful ‘Translational control’ meeting at the Cold Spring
Harbor Laboratory. Translation is a complex and highly
regulated multi-step process, fundamental to all forms of
life. The meeting covered a diverse range of topics, experi-
mental systems and approaches. Here we report a few of the
highlights from the major themes of the meeting, focusing
mainly on contributions not published at the time of writing.
F Fa ac ct to or rs s   a an nd d   c co on nt tr ro ol ls s   i in n   t tr ra an ns sl la at ti io on n   a an nd d   m mR RN NA A   d de ec ca ay y
ATP-dependent RNA helicases are important for many
aspects of RNA biology, including translation and mRNA
decay. One of the key proposed roles for RNA helicases in
eukaryotic translation initiation is to facilitate scanning of
the mRNA 5′ untranslated region (UTR) by the small ribo-
somal subunit and associated translation factors. Gerhard
Wagner (Harvard Medical School, Boston, USA) used
nuclear magnetic resonance (NMR) chemical shift mapping,
as well as comparisons to the structurally similar nuclear
cap-binding complex, to provide an overview of interactions
involved in mRNA cap recognition and 5′ UTR scanning.
Wagner described how specific domains of eukaryotic
initiation factor (eIF) 4G interact with the archetypal ATP-
dependent RNA helicase, eIF4A, and the associated factor
eIF4H. The data were combined into a model depicting how
the eIF4A-eIF4G complex could associate with the ribo-
somal leading edge while still maintaining interaction with
the cap-binding protein eIF4E.
Andrey Pisarev (State University of New York, Brooklyn,
USA) presented a classical biochemical purification of an
activity that restored translation of structured 5′ UTR-
containing mRNAs in a reconstituted in vitro system. This
protein, DHX29, is a DExH-domain protein with putative
ATP-dependent RNA helicase activity. Although little
evidence for helicase activity was found, the protein was
shown to associate with the small ribosomal subunit and to
possess nucleotide triphosphatase (NTPase) activity. DHX29
was also shown to promote efficient recruitment of the small
ribosomal subunit to structured 5′ UTR mRNAs in a manner
that is synergistic with eIF4A, defining DHX29 as a novel
factor required for scanning on structured 5′ UTRs.
Nancy Standart (University of Cambridge, UK) presented a
mutational analysis targeting the helicase domain of the
protein DDX6 (also called p54 and Dhh1 in different
organisms). DDX6 has been described as a translational
repressor (for instance as part of the cytoplasmic poly-
adenylation element binding (CPEB) repressor complex)
and as a component and assembling factor of processing
bodies (P-bodies) involved in mRNA decay. Specific muta-
genesis of the helicase domain impacted upon both of these
functions, as well as leading to changes in the stoichiometry
of the CPEB repressor complex.
mRNA decay and translation initiation are complex
competing processes. A common perception is that mRNAs
must leave the polysomal pool; that is, they must be
translationally repressed to interact with enzymes respon-
sible for mRNA decay. Evidence that severe stresses lead to
translational repression and induce the accumulation of P-
bodies supports this view. Wenqian Hu (Case Western
Reserve University, Cleveland, USA) presented evidence that,
in unstressed budding yeast, all three steps of mRNA decay
(deadenylation, decapping and exonucleolytic digestion) can
occur while mRNAs are still associated with the polysome.
This raises a number of intriguing questions, such as what
happens under stress conditions where P-bodies are induced,
and what targets mRNAs for degradation?
In higher eukaryotes the 5′ mRNA cap-activated
deadenylase PARN enables the targeting of mRNAs for
degradation. Here the deadenylase would compete with thetranslational machinery for the mRNA 5′ end. A molecular
model for cap-dependent PARN activation was presented by
Anders Virtanen (Uppsala University, Sweden) based upon
crystal structures of free PARN, a poly(A)-bound form and a
new crystal structure determined by Virtanen and colleagues
- PARN with cap analog. In this structure PARN forms a
dimer, with one molecule in an open and the other in a closed
conformation, in which both cap and poly(A) sites partially
overlap. These data suggest a model where one PARN mono-
mer interacts with the cap structure to activate the nuclease
domain of the partner PARN molecule, and they provide
insight into the cap dependence of the nuclease.
MicroRNAs (miRNAs) have variably been shown to down-
regulate both mRNA decay and translation, again highlighting
the connection between these pathways. In her plenary
presentation, Joan Steitz (Yale University, New Haven, USA)
presented studies by Shobha Vasudevan that add further
intricacy to miRNA-mediated control of gene expression.
First, miRNAs can be stimulatory as well as repressive, and
second, the stimulatory phase of their activity may be
restricted to quiescent cells. Two presentations highlighted
further complexities with regard to the source of miRNAs.
Christine Ender (Max Planck Institute of Biochemistry,
Munich, Germany) and Ashesh Saraiya (University of
California, San Fransisco, USA) both showed that, in human
cells and Giardia parasites, respectively, RNA fragments
derived from small nucleolar RNAs control translation
initiation in an Argonaute- and Dicer-dependent manner,
giving them many of the hallmarks of miRNAs.
D Di iv ve er rs si if fi ic ca at ti io on n   o of f   t tr ra an ns sl la at ti io on n   f fa ac ct to or r   a ac ct ti iv vi it ti ie es s
Studies presented at the meeting challenge our current view
of the functions of several individual factors, in that a
number of factors initially defined as being involved in one
process might have broader or different roles. Stefano Biffo
(San Raffaele Science Institute, Milan, Italy) used hetero-
zygous eIF6-null mouse embryonic fibroblasts to show a
defect in insulin-stimulated translation with little change in
ribosome biogenesis. Hence, eIF6, which was initially identi-
fied as a ribosome subunit anti-association factor and later
defined as a factor involved in large ribosomal subunit bio-
genesis in the nucleus, can once again be tied to the
regulation of translation initiation in the cytoplasm.
eIF5A is also a factor with a long history of suggested
functions. This factor is particularly intriguing by virtue of a
unique, essential, post-translational modification of a lysine
residue to hypusine. Preeti Saini (National Institutes of
Health, Bethesda, USA) presented studies that extend the list
of suggested eIF5A functions by implicating the budding yeast
factor in the process of translation elongation. Results were
also presented linking eIF5A with eukaryotic elongation factor
2 (eEF2), thus providing mechanistic detail for this proposed
function. In addition, using inhibitors of hypusine
modification in human cells, Michael Matthews (University
of Medicine and Dentistry of New Jersey, Newark, USA)
proposed that eIF5A plays roles in nonsense-mediated
mRNA decay as well as affecting the translation of only a
subset of mRNAs.
More evidence for functional divergence of individual factors
came from the mitochondrial translation initiation system.
Umesh Varshney (State University of New York, Albany,
USA) presented mutant complementation studies in
Escherichia coli showing that mitochondrial initiation factor 2
(IF2mt) serves the functions of both the bacterial proteins
IF1 and IF2. This difference from bacterial translation was
explained by an insertion of 37 amino acids in IF2mt that is
necessary for IF1 functions.
In a study of E. coli translation Haiou Qin (University of
Pennsylvania, Philadelphia, USA) used single-molecule
fluorescence resonance energy transfer (FRET) studies to
support the maintenance of IF2 on the 70S ribosome
during recruitment of the EF-Tu elongation factor. As both
factors share an overlapping binding site on the ribosome,
this was a highly unexpected finding. Qin presented a
model to accommodate the coexistence of both proteins,
and discussed the potential for a sustained interaction
between IF2 and the ribosome during the first round of
elongation.
R Ri ib bo os so om me e   d dy yn na am mi ic cs s, ,   h hy yb br ri id d   s st ta at te es s   a an nd d   r ra at tc ch he et ti in ng g
The translating ribosome has three tRNA-binding sites: A, P
and E. Hybrid A/P and P/E intermediate states were
originally proposed by Moazed and Noller to explain tRNA
movement through the ribosome (translocation) catalyzed by
the G protein EF-G (EF2). Understanding the mechanism of
translocation is a major focus in the field. Joachim Frank
(Columbia University, New York, USA) presented the results
of cryo-electron microscopic reconstructions performed at
low magnesium concentrations that, for the first time
visualize two forms of the 70S ribosome with two tRNAs
bound. Both ‘pre-ratcheted’ (tRNAs bound in the A and P
sites) and ‘ratcheted’ (A/P and P/E hybrid state with tRNAs
bound) complexes were seen, suggesting that ratcheting is
spontaneous. In the ratcheted state tRNA anticodon stem
loops reside in the A and P sites of the 30S subunit, whereas
the acceptor ends are found in the P and E sites, respectively,
of the 50S subunit. tRNA movement in the 50S is accom-
panied by a counter-clockwise rotation (ratcheting) of the
small subunit in which multiple changes in the relative
positioning of several ribosomal RNA and protein compo-
nents occur (Figure 1). Thus, the ribosome is a dynamic
rather than a rigid structure.
Sarah Walker (Ohio State University, Columbus, USA)
analyzed the effects of 23S rRNA mutations predicted to
inhibit P/E site formation in a steady-state kinetic study of
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that a P/E hybrid tRNA forms before the A/P hybrid and
that EF-G•GTP hydrolysis to a bound EF-G•GDP•Pi state
can precede tRNA movement. In his plenary presentation,
Jody Puglisi (Stanford University School of Medicine, USA)
continued the ‘dynamic ribosome’ theme, describing single-
molecule FRET experiments with labeled tRNAs and/or
rRNAs to analyze subunit joining, peptide-bond formation
and translocation in real time. He noted that his data
complemented the structural and kinetic experiments of
others, demonstrating that A-site tRNA binding and
peptide-bond formation favors ribosome ratcheting to the
hybrid state and that EF-G-mediated translocation reverses
the ribosome conformational change, and that together
these events should drive unidirectional motion of the
ribosome ready for the next elongation cycle.
M Me em mo or ry y   a an nd d   b br ra ai in n   d di is se ea as se e
mRNA-specific translation is regulated by a family of proteins
called 4E binding proteins (4E-BPs), which compete with
eIF4G for binding to the 5′ cap binding factor eIF4E. 4E-BP-
eIF4E binding is regulated by mTOR (target of rapamycin)-
dependent phosphorylation of the 4E-BPs. Knockout mice
have revealed that the 4E-BPs are important for long-term
memory and other physiological responses. Michael Bidinosti
(McGill University, Montreal, Canada) presented the iden-
tification of a novel 4E-BP2 post-translational modification
that occurs during early brain development: asparagine
deamination to aspartate. The modification influences 4E-
BP2 binding to the mTOR partner protein, Raptor, and might
be important for establishing the dendritic network in
mammalian neurons.
Claudia Bagni (Catholic University of Leuven, Belgium)
described work showing that the cytoplasmic FMRP-inter-
acting protein (CYFIP1), a protein that interacts with the
fragile X mental retardation protein (FRMP), is a neuronal
4E-BP. Interestingly, this protein lacks the classical eIF4E-
binding motif and instead possesses a structurally related
motif. CYFIP1 binds eIF4E and FMRP to repress neuronal
translation of certain FMRP targets. Bagni showed that
neuronal stimulation led to both CYFIP1 dissociation from
eIF4E and activation of local protein synthesis at synapses.
Wayne Sossin (McGill University, Montreal, Canada) pre-
sented experiments examining the mechanism of serotonin-
mediated TOR activation of translation in neurons in the sea
slug  Aplysia californica, a model organism with a simple
nervous system used to study synaptic plasticity in response
to stress. Sossin reported that by deleting the TOR-binding
site in ribosomal protein S6 kinase (S6K) to create a
dominant-negative mutation, it was found that the S6K was
an important mediator of active translation in the neuron
cell body and for long term-synaptic plasticity, suggesting
that S6K is an important TOR target for long-term memory
formation.
Inherited mutations in genes encoding eIF2B subunits cause
fatal human ‘eIF2B-related disorders’ of the brain. Orna
Elroy-Stein (Tel-Aviv University, Israel) described the
generation of a knock-in mouse model for the disease, which
reproduced important aspects of the human condition,
including delayed development of white matter and a
decrease in the layer of myelin wrapping axons. Isolated
homozygous knock-in primary astrocytes exhibited marked
deflects in cell culture. This mouse model will clearly be
helpful in understanding the related human pathology.
I In nf fe ec ct ti io on n   a an nd d   i im mm mu un ni it ty y
Like other viruses, human cytomegalovirus (HCMV) must
inveigle the host’s translation machinery into synthesizing
viral proteins. Many viruses modify translation factors to
shut off host gene expression, thereby reducing competition
between host and viral genes. Cesar Perez (New York
University School of Medicine, USA) described experiments
showing that rather than shutting off host translation,
HCMV takes a different approach and elevates expression of
both the eIF4F complex (consisting of eIF4E, eIF4G and
eIF4A) and poly(A)-binding protein (PABP) to promote viral
protein synthesis and replication. PABP expression is
controlled translationally, whereas transcriptional changes
mediate the eIF4F response.
One common host innate immune response to viral infection
is activation of protein kinase R (PKR), which phosphorylates
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F Fi ig gu ur re e   1 1
Transfer RNA hybrid states. The figure depicts two cryo-electron-
microscopic reconstructions of the ribosome, one (a a) showing two
tRNAs (green and magenta) in the canonical A (A/A) and P (P/P)
positions, the other (b b) showing them in the hybrid A/P and P/E positions
relative to the 50S subunit (blue) with the 30S subunit (yellow; see inset)
computationally removed. tRNA reconfiguration accompanies a
spontaneous rotation of the small subunit with respect to the large
subunit (ratchet motion). The repositioning of the tRNAs accompanies a
change in their immediate environment that is caused by the rotation of
the small subunit. Figure courtesy of Xabier Agirrezabala and Joachim
Frank, with permission from Quarterly Reviews in Biophysics.
(a) (b)eIF2α; this in turn helps to shut down protein synthesis in
infected cells. Poxviruses have evolved a variety of strategies
to counter PKR. Stefan Rothenburg (National Institutes of
Health, Bethesda, USA) presented evidence that the rate of
PKR evolution is more rapid than for other eIF2α kinases
throughout vertebrates, while Adam Geballe (Fred
Hutchinson Cancer Research Center, Seattle, USA) presented
evidence that this is so even across different ape species. Both
explained this by co-evolutionary pressures on both the host
PKR and poxvirus-encoded K3L and E3L, proteins that are
known to target and inactivate PKR, and included results of
mutation analyses in yeast to support this hypothesis.
Bradley Joyce (Indiana University School of Medicine,
Indianapolis, USA) presented evidence that the pathogenic
protist Toxoplasma gondii expresses novel members of the
eIF2α kinase family - called TgIF2K-A and TgIF2K-B - that
have a novel gene architecture and mediate translational
control in response to cellular stresses. Joyce also showed
that eIF2α phosphorylation accompanies the developmental
transition from the invasive tachyzoite form to the quiescent
bradyzoite that is required for persistence in the host.
Whereas TgIF2K-A was regulated by conditions that evoke
an endoplasmic reticulum stress (conditions that interfere
with the functions of this organelle) in a manner similar to
the mammalian eIF2 kinase PEK/PERK, TgIF2K-B is a
novel member of the kinase family whose activation
mechanism remains unknown. The study clearly implicates
a role for eIF2α kinase-mediated translational control in
developmental switches during the parasite life cycle.
The field of translational control has burgeoned over the
years and now represents a very large community of
scientists with connections to almost every aspect of biology.
It is clear the future is bright for translational control. There
are many key areas for future studies, including further
structure-function analyses to increase our understanding of
the molecular details underlying translational control and
extending the already wide-ranging connections with
development and disease. The ribosome remains a major
antimicrobial antibiotic target and we are sure that new
biotechnological and therapeutic applications will emerge,
strengthening links between ‘translational control’ and
‘translational medicine’.
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